Aju Ib Investment Co., Ltd. Rapt Therapeutics, Inc. Transaction History
Aju Ib Investment Co., Ltd.
- $91.6 Million
- Q2 2025
A detailed history of Aju Ib Investment Co., Ltd. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Aju Ib Investment Co., Ltd. holds 12,437 shares of RAPT stock, worth $361,916. This represents 0.11% of its overall portfolio holdings.
Number of Shares
12,437
Previous 99,503
87.5%
Holding current value
$361,916
Previous $121,000
18.18%
% of portfolio
0.11%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding RAPT
# of Institutions
13Shares Held
6.5MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.44MShares$71 Million0.0% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$46.5 Million52.54% of portfolio
-
Column Group LLC San Francisco, CA1.33MShares$38.7 Million16.17% of portfolio
-
Kpcb Xv Associates, LLC649KShares$18.9 Million43.54% of portfolio
-
Ponoi Ii Management, LLC San Francisco, CA145KShares$4.23 Million9.14% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $863M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...